Search

Offer your patients the vision they remember

A new national media campaign by ACUVUE

LM Acuvue2
How can we help you attract new presbyopic patients? This apparently simple question is a crucial point for the growth of your practice – something in which we try to help you every day. Our research shows that presbyopic patients wearing multifocal contact lenses are extremely valuable, as they are more loyal and they are higher spenders, so they generate more value for your practice*.

Many people may not have heard the term presbyopia before and it can sound worrying when heard for the first time. Communicating that this is a common, easily managed condition will go a long way to help put them at ease.

That’s what inspired our national media campaign focusing on ACUVUE® Multifocal Contact Lenses. After the great success of our national media campaign in Autumn 2021, this new effort aims to help you drive growth by encouraging trials of ACUVUE® Multifocal Contact Lenses.

Our campaign aims to remind new and returning presbyopic patients that a great vision experience is still possible, with a vision solution that fits around their needs. We have created a suite of dedicated assets you can utilise to attract these patients to your practice by speaking in a language they will find familiar and at the same time inspiring.
We believe that enjoying clear, comfortable vision helps people make experiences they’ll cherish – at all ages. That’s why we want to help you offer your patients the vision they remember.

Discover more and download the assets

*MF Segmentation 2020 UK, Total Sample N=1500 45-64 year olds suffering from Presbyopia (n=1246 glasses only wearers, n=114 MF CL wearers).

Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For complete information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use or visit https://jnjvisionpro.co.uk/

© Johnson & Johnson Medical Ltd 2022. ACUVUE® is a registered trademarks of Johnson & Johnson. 


Advertisement

  • Advertorial brought to you by:
  • UpdatedMasterbrandworkingfile copy